— Know what they know.
Not Investment Advice

IZTC NASDAQ

Invizyne Technologies Inc. Common Stock
1W: -22.3% 1M: -25.0% 3M: -1.3%
$16.50
Last traded 2025-03-10 — delisted
NASDAQ · Healthcare · Biotechnology · $157.2M mcap · 2M float · 2.15% daily turnover

Balance Sheet Trends

Total Assets
$6M -54.2% ▼
Total Liabilities
$3M -1.5% ▼
Shareholders Equity
$3M -67.4% ▼
Cash & Investments
$3M -68.7% ▼
Total Debt
$917K -20.7% ▼
Net Debt
-$2M +75.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2024FY2025
— Assets —
Cash$10M$3M
Short-Term Investments$0$0
Cash & ST Investments$10M$3M
Net Receivables$0$0
Inventory$0$0
Other Current Assets$1M$900K
Total Current Assets$11M$4M
Property, Plant & Equip.$2M$2M
Goodwill & Intangibles$0$0
Long-Term Investments$0$0
Other Non-Current Assets-$230K-$177K
Total Non-Current Assets$2M$2M
Total Assets$13M$6M
— Liabilities —
Accounts Payable$924K$1M
Short-Term Debt$0$0
Deferred Revenue$0$0
Other Current Liabilities$409K$2M
Total Current Liabilities$1M$2M
Long-Term Debt$1M$917K
Other Non-Current Liab.$124K$90K
Total Non-Current Liabilities$1M$1M
Total Liabilities$3M$3M
— Equity —
Common Stock$8$8
Retained Earnings-$12M-$21M
Accumulated OCI$0$0
Total Stockholders Equity$10M$3M
Total Liabilities & Equity$13M$6M
— Key Metrics —
Total Debt$1M$917K
Net Debt-$9M-$2M
Total Investments$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms